Cyclobutanecarboxylic acid, 3-[(8'-chloro-2',3'-dihydro-2'-oxospiro[cyclohexane-1,4'(1'H)-quinazolin]-5'-yl)oxy]-, trans-

Cyclobutanecarboxylic acid, 3-[(8'-chloro-2',3'-dihydro-2'-oxospiro[cyclohexane-1,4'(1'H)-quinazolin]-5'-yl)oxy]-, trans- Suppliers list
Company Name: TargetMol Chemicals Inc.
Tel: +17819995354
Email: marketing@targetmol.com
Products Intro: Product Name:PDE7-IN-3
CAS:908570-13-8
Package:50mg;2380USD|25mg;1820USD|100mg;3100USD
Company Name: Wuhan Jingkangen Biomedical Technology Co., Ltd  
Tel: 13720134139 086-15871494362 13720134139
Email: orders@jknbiochem.com
Products Intro: Product Name:PDE7-IN-3
CAS:908570-13-8
Purity:98% Package:1g;5g
Company Name: Shanghai Easy CDMO Co.,Ltd  
Tel: 021-61734564 13854185395;
Email: info@easycdmo.com
Products Intro: Product Name:Cyclobutanecarboxylic acid, 3-[(8'-chloro-2',3'-dihydro-2'-oxospiro[cyclohexane-1,4'(1'H)-quinazolin]-5'-yl)oxy]-, trans-
CAS:908570-13-8
Purity:98% HPLC Package:10g;100g;1kg;10kg
Company Name: TargetMol Chemicals Inc.  
Tel: 15002134094
Email: marketing@targetmol.cn
Products Intro: Product Name:PDE7-IN-3
CAS:908570-13-8
Package:50mg/RMB 16800;25mg/RMB 12800;100mg/RMB 21500
Company Name: Aikon International Limited  
Tel: 025-58859352 18651614124
Email: 2881516338@qq.com
Products Intro: CAS:908570-13-8
Purity:95%+ Package:1g;5g;10g

Cyclobutanecarboxylic acid, 3-[(8'-chloro-2',3'-dihydro-2'-oxospiro[cyclohexane-1,4'(1'H)-quinazolin]-5'-yl)oxy]-, trans- manufacturers

  • PDE7-IN-3
  • PDE7-IN-3 pictures
  • $2380.00 / 50mg
  • 2025-10-27
  • CAS:908570-13-8
  • Min. Order:
  • Purity:
  • Supply Ability: 10g
Cyclobutanecarboxylic acid, 3-[(8'-chloro-2',3'-dihydro-2'-oxospiro[cyclohexane-1,4'(1'H)-quinazolin]-5'-yl)oxy]-, trans- Basic information
Product Name:Cyclobutanecarboxylic acid, 3-[(8'-chloro-2',3'-dihydro-2'-oxospiro[cyclohexane-1,4'(1'H)-quinazolin]-5'-yl)oxy]-, trans-
Synonyms:Cyclobutanecarboxylic acid, 3-[(8'-chloro-2',3'-dihydro-2'-oxospiro[cyclohexane-1,4'(1'H)-quinazolin]-5'-yl)oxy]-, trans-;PDE7-IN-3
CAS:908570-13-8
MF:C18H21ClN2O4
MW:364.82
EINECS:
Product Categories:
Mol File:908570-13-8.mol
Cyclobutanecarboxylic acid, 3-[(8'-chloro-2',3'-dihydro-2'-oxospiro[cyclohexane-1,4'(1'H)-quinazolin]-5'-yl)oxy]-, trans- Structure
Cyclobutanecarboxylic acid, 3-[(8'-chloro-2',3'-dihydro-2'-oxospiro[cyclohexane-1,4'(1'H)-quinazolin]-5'-yl)oxy]-, trans- Chemical Properties
Boiling point 562.9±50.0 °C(Predicted)
density 1.43±0.1 g/cm3(Predicted)
pka4.36±0.40(Predicted)
form Solid
color White to off-white
Safety Information
MSDS Information
Cyclobutanecarboxylic acid, 3-[(8'-chloro-2',3'-dihydro-2'-oxospiro[cyclohexane-1,4'(1'H)-quinazolin]-5'-yl)oxy]-, trans- Usage And Synthesis
UsesPde7-in-3 (example 2) is an inhibitor of the phosphodiesterase PDE7 with potential analgesic activity. PDE7-IN-3 can be used to study inflammatory, neuropathic, visceral and nociceptive pain[1].
IC 50PDE7
References[1] Cox Peter, et al. Use of combinations of PDE7 inhibitors and alpha-2-delta ligands for the treatment of neuropathic pain. World Intellectual Property Organization, WO2006092692 A1. 2006-09-08.
Cyclobutanecarboxylic acid, 3-[(8'-chloro-2',3'-dihydro-2'-oxospiro[cyclohexane-1,4'(1'H)-quinazolin]-5'-yl)oxy]-, trans- Preparation Products And Raw materials
Tag:Cyclobutanecarboxylic acid, 3-[(8'-chloro-2',3'-dihydro-2'-oxospiro[cyclohexane-1,4'(1'H)-quinazolin]-5'-yl)oxy]-, trans-(908570-13-8) Related Product Information

  • HomePage | Member Companies | Advertising | Contact us | Previous WebSite | MSDS | CAS Index | CAS DataBase | Privacy | Terms | About Us
  • All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.
    According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.
  • Copyright © 2023 ChemicalBook All rights reserved.